You are here

Clinical Trials: Central Nervous System Diseases

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Thursday, July 8, 2021 - 12:00
Condition:   Alzheimer's Disease
Intervention:   Biological: human umbilical cord blood derived mesenchymal stem cells
Sponsors:   Samsung Medical Center;   Medipost Co Ltd.
Not yet recruiting
Posted: Thursday, July 8, 2021 - 12:00
Condition:   Stroke
Intervention:   Biological: it-hMSC
Sponsor:   Peking University Third Hospital
Recruiting
Posted: Wednesday, June 16, 2021 - 12:00
Condition:   Parkinson Disease
Interventions:   Biological: HB-adMSCs;   Other: Placebo
Sponsors:   Hope Biosciences Stem Cell Research Foundation;   Hope Biosciences
Recruiting
Posted: Thursday, May 6, 2021 - 12:00
Conditions:   Ciliopathies;   Nephronophthisis;   Senior-Loken Syndrome;   Joubert Syndrome;   Jeune Syndrome;   Bardet-Biedl Syndrome
Interventions:   Other: Blood sample;   Other: Urine sample
Sponsor:   Assistance Publique - Hôpitaux de Paris
Not yet recruiting
Posted: Thursday, May 6, 2021 - 12:00
Conditions:   Multiple System Atrophy;   Parkinsonism;   Multiple System Atrophy, Parkinson Variant
Interventions:   Biological: Autologous Adipose Mesenchymal Stem Cell Implantation;   Biological: Allogeneic Umbilical Cord Mesenchymal Stem Cell Implantation;   Biological: Allogeneic Umbilical Cord Mesenchymal Stem Cell and Adipose Secretome Implantation
Sponsor:   Indonesia University
Recruiting
Posted: Monday, April 19, 2021 - 12:00
Condition:   ALS (Amyotrophic Lateral Sclerosis)
Interventions:   Drug: MNC (Mononuclear cells);   Drug: Placebo / Saline
Sponsor:   Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Not yet recruiting
Posted: Tuesday, March 23, 2021 - 12:00
Condition:   Ischemic Stroke
Interventions:   Biological: Umbilical Cord-derived Mesenchymal Stem Cells;   Drug: Placebo
Sponsor:   General Hospital of Shenyang Military Region
Recruiting
Posted: Tuesday, March 23, 2021 - 12:00
Conditions:   Spinal Cord Injury, Acute;   Spinal Cord Injury at C4 Level With Complete Lesion;   Spinal Cord Injury at C5-C7 Level With Complete Lesion
Intervention:   Biological: Neural precursor cells derived from human embryonic stem cell line
Sponsors:   S.Biomedics Co., Ltd.;   Linical Co., Ltd.;   Yonsei University
Not yet recruiting
Posted: Tuesday, February 9, 2021 - 12:00
Condition:   Amyotrophic Lateral Sclerosis
Interventions:   Biological: Lenzumestrocel;   Drug: Riluzole
Sponsor:   Corestem, Inc.
Recruiting
Posted: Thursday, December 3, 2020 - 12:00
Condition:   Amyotrophic Lateral Sclerosis
Intervention:   Drug: Mesenchymal stem cells isolated from Wharton's jelly
Sponsors:   Polski Bank Komorek Macierzystych JSC (PBKM);   The National Centre for Research and Development
Recruiting

Pages